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We report on our initial genetic linkage studies of schizophrenia in the genetically isolated population of the
Afrikaners from South Africa. A 10-cM genomewide scan was performed on 143 small families, 34 of which were
informative for linkage. Using both nonparametric and parametric linkage analyses, we obtained evidence for a
small number of disease loci on chromosomes 1, 9, and 13. These results suggest that few genes of substantial
effect exist for schizophrenia in the Afrikaner population, consistent with our previous genealogical tracing studies.
The locus on chromosome 1 reached genomewide signiﬁcance levels (nonparametric LOD score of 3.30 at marker
D1S1612, corresponding to an empirical P value of .012) and represents a novel susceptibility locus for schizo-
phrenia. In addition to providing evidence for linkage for chromosome 1, we also identiﬁed a proband with a
uniparental disomy (UPD) of the entire chromosome 1. This is the ﬁrst time a UPD has been described in a patient
with schizophrenia, lending further support to involvement of chromosome 1 in schizophrenia susceptibility in the
Afrikaners.
Introduction
Schizophrenia (MIM 181500) is a severemental disorder
affecting 1% of the world population and is character-
ized by psychotic symptoms and by cognitive, affective,
and psychosocial impairment. There is substantial evi-
dence that schizophrenia has a genetic basis (Gottesman
and Shields 1982; Tsuang and Faraone 1994). For ex-
ample, concordant diagnosis of schizophrenia is more
than two times higher for MZ twins (41%–65% con-
cordance) than for DZ twins (0%–28% concordance)
and other ﬁrst-degree relatives of schizophrenic individ-
uals (for a review, see Cardno and Gottesman [2000]).
It seems clear that multiple gene loci and environmental
factors inﬂuence susceptibility to schizophrenia. Under-
standing of the role of individual genes in the disorder,
however, remains limited.
Over the past few years, several searches for suscep-
tibility loci have been undertaken. Genomewide linkage
scans have suggested that susceptibility loci may be pres-
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ent on several chromosomes (Coon et al. 1994; Moises
et al. 1995; Blouin et al. 1998; Faraone et al. 1998;
Levinson et al. 1998; Hovatta et al. 1999; Rees et al.
1999; Williams et al. 1999; Bailer et al. 2000; Brzus-
towicz et al. 2000; Ekelund et al. 2000; Camp et al.
2001; Gurling et al. 2001; Paunio et al. 2001; DeLisi
et al. 2002a, 2002b; Devlin et al. 2002; Straub et al.
2002). For most implicated regions, both positive and
negative replication studies have been reported. In ad-
dition to locus heterogeneity, differences in diagnostic
and ascertainment procedures, analytical methods, and
sample conﬁguration and size may help explain differ-
ences in the results. Ethnic heterogeneity might also be
a contributing factor, since families studied in the initial
genome scans were drawn mostly from the genetically
diverse populations of Europe and the United States.
More recently, genetic studies of schizophrenia have
employed genetically isolated populations from Finland
(Hovatta et al. 1999; Ekelund et al. 2000; Paunio et al.
2001), Sweden (Lindholm et al. 2001), Iceland (Ste-
fansson et al. 2002), Quebec (Maziade et al. 2002),
Costa Rica (DeLisi et al. 2002a), and two Micronesian
islands: Palau (Camp et al. 2001; Devlin et al. 2002)
and Kosrae (Wijsman et al. 2003). It is possible that,
in these populations, there will be fewer susceptibility
loci and alleles (de la Chapelle and Wright 1998; Ober
and Cox 1998). In addition, founder populations often
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exhibit less environmental heterogeneity than do other
populations and allow detailed genealogical research
and reconstruction of extended multigenerational ped-
igrees (Peltonen et al. 2000). Availability of such large
pedigrees should facilitate the detection of linkage
(Wijsman and Amos 1997; Dyer et al. 2001). Despite
these potential advantages, it must be noted that the
outcome of studies of complex traits in an isolated pop-
ulation will depend greatly on the particular demo-
graphic characteristics and historical circumstances sur-
rounding the founding of the population.
Here, we report the results of our initial genetic link-
age studies of schizophrenia in the genetically isolated
population of the Afrikaners from South Africa. The
Afrikaners descended from a small number (1,000–
2,000) of immigrants, primarily of Dutch origin, who
settled in the Cape in 1652. These immigrants spread
inland, with splinter groups forming small, geographi-
cally isolated communities. Because of language differ-
ences (the Afrikaans language is derived from Dutch)
and religious practices (most Afrikaners were members
of the Dutch Reformed Church), the Afrikaners re-
mained isolated. The population expanded over 13–15
generations almost entirely through reproduction, since
immigration subsequent to the founding was minimal.
In the early generations, consanguinity was common.
The Afrikaner population, which is currently 3 million,
has expanded in relative genetic isolation, as is evident
from the unusually high frequency of certain rare Men-
delian disorders (e.g., variegate porphyria), the low di-
versity of the associated allelic variants, and the large
extent (8–11 cM) of conserved haplotypes around dis-
ease genes (Hayden et al. 1980; Brink et al. 1987; Ro-
sendorff et al. 1987; Leitersdorf et al. 1989; Torrington
and Viljoen 1991; Brink et al. 1995; Pronk et al. 1995;
Goldman et al. 1996; Warnich et al. 1996; Groenewald
et al. 1998; Roby et al. 1999).
In a previous study, we described our ongoing efforts
to document the genealogical history of a sample of
Afrikaner individuals with schizophrenia (Karayiorgou
et al. 2004). We traced the ancestry of 98 probands
with schizophrenia. It was remarkable that we found
that 87 of them descended from a single couple who
immigrated to South Africa ∼12.5 generations ago. This
particular line of descent has not, to our knowledge,
been described previously for any other disorder studied
in the Afrikaner population (M.T., unpublished data).
These results suggest that the affected individuals in this
population may share a small number of disease alleles.
In this setting, linkage and association scans hold ex-
ceptional promise, and the present article reports results
from an initial scan for linkage in this population.
Material and Methods
Sample Recruitment
A collaborative project between the Laboratory of Hu-
man Neurogenetics at the Rockefeller University and two
major psychiatric hospitals in South Africa was under-
taken, with the goal of ascertaining and evaluating Af-
rikaner probands with a history of psychotic illness and
their families for a genetic study. The participating hos-
pitals were the Weskoppies Hospital in Pretoria, an ac-
ademic hospital afﬁliated with the University of Pretoria,
and the Valkenberg Hospital, which is afﬁliated with the
University of Capetown. The Afrikaner families in our
study were recruited from the regions of Tshwane (for-
merly known as Pretoria), Limpopo (formerly North-
ern Transvaal), and Mpumalanga (formerly the Eastern
Transvaal), as well as from the greater Cape area. The
study was approved by institutional review boards at all
sites (Rockefeller University, University of Pretoria, and
University of Capetown). Appropriate written informed
consent was obtained from all study participants. A de-
tailed description of our sample is available elsewhere
(Karayiorgou et al. 2004).
Clinical Evaluation
The Diagnostic Interview for Genetic Studies (DIGS)
(Nurnberger et al. 1994), after being translated and
back-translated into Afrikaans, was the diagnostic in-
strument of choice. The DIGS was developed at the Na-
tional Institute of Mental Health Diagnostic Centers for
Psychiatric Linkage Studies and was speciﬁcally designed
for the diagnosis of schizophrenia, schizoaffective dis-
order, major affective disorders, and anxiety disorders
in genetic research. All diagnostic interviews were con-
ducted in person by specially trained clinicians. Specif-
ically, two psychiatrists and one clinical psychologist
with a minimum of 10 years of clinical experience each
were specially trained in the use of the DIGS and in the
research application of the Diagnostic and Statistical
Manual–4th Edition (DSM-IV) (American Psychiatric
Association 1994). On the basis of information gathered
in the DIGS, the clinical interviewers assigned appro-
priate diagnoses according to the DSM-IV. After each
interview, diagnosticians completed (a) DSM-IV check-
lists for each category in which positive symptoms were
identiﬁed in the DIGS; (b) a narrative chronologic sum-
mary of prodromal traits, symptom onset, and func-
tional impairment; and (c) an English-language data
summary form of selected DIGS items.
Ongoing reliability studies between the Afrikaner cli-
nicians, the U.S. clinicians who conducted the diagnostic
evaluations for our U.S.-based genetic schizophrenia sam-
ple, and the U.S. investigator who trained all the clinicians
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Figure 1 Informative pedigrees included in linkage analyses. Black coloring indicates affected individuals in LC I, and dark and light gray
coloring indicate individuals in LCs II and III, respectively.
show 190% agreement for DSM-IV diagnoses. Reliability
exercises consisted of yearly reliability interviews between
all the clinicians, as well as review of videotapes of an
additional two interviews per interviewer.
Affected Status Deﬁnitions
For the genetic linkage analysis, we used three phe-
notypic liability classes (LCs) (Straub et al. 1995; Kend-
ler et al. 1996). LC I comprises the “core schizophrenic
phenotypes” of schizophrenia and depressed-type-only
schizoaffective disorder (family data suggest that the two
diagnoses are alternative expressions of the same ge-
notypes [Cloninger 1989]). LC II combines the LC I
cases with all psychotic disorders, including primarily
cases with schizoaffective disorder of mainly affective
course, as well as some cases with bipolar disorder with
psychotic symptoms, psychotic depression, and psycho-
sis not otherwise speciﬁed (NOS). LC III combines the
LC II cases with all psychiatric disorders, including de-
pression, anxiety disorders, and ethanol dependence.
Family Sample
The entire genotyped sample includes 173, 205, and
253 individuals in LCs I, II, and III, respectively. These
individuals are organized into 143 small families and
1137 relative pairs (including 79 parent-child pairs, 35
sib pairs, 15 avuncular pairs, 4 grandparent-grandchild
pairs, and 4 cousin pairs). Thirty-four of these families
are informative for linkage (ﬁg. 1). The remaining 110
are useful for allele frequency estimation and transmis-
sion disequilibrium testing. This analysis will be de-
scribed elsewhere. The 34 families that are informative
for linkage include 62, 81, and 100 individuals in LCs
I, II, and III, respectively. Of the 19 cases included in
LC II but not LC I, 10 meet criteria for schizoaffective
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Figure 2 Single-point analysis results. Single-point Kong and Cox (1997) nonparametric LOD scores calculated using the SALL scoring
statistic are shown. Results are summarized throughout the genome for three phenotypic LCs: LC I (circles), LC II (triangles), and LC III
(squares).
disorder of mainly affective course, and 9 meet the cri-
teria for other psychotic disorders.
Genomewide Screening
DNA from all study participants was extracted from
24 ml of EDTA-treated blood, according to standard
procedures (Ciulla et al. 1988). In addition to affected
individuals, we collected DNA samples for genotyping
from ﬁrst-degree relatives (parents and siblings) when-
ever possible. A genomewide screen was performed at
the Center for Inherited Disease Research (CIDR). A
total of 602 samples was screened using 388 ﬂuorescent
microsatellite markers. The marker set was composed
primarily of trinucleotide and tetranucleotide repeat
markers and was based on the Marshﬁeld Genetics ver-
sion 8 screening set, available for purchase from Re-
search Genetics (∼10% of the marker loci are different
between the CIDR marker set and Marshﬁeld version
8) (Center for Medical Genetics Web site; CIDR Human
Marker Set Web site). The average spacing of the mark-
ers used was 9 cM, with one gap 120 cM. The average
heterozygosity of the markers used was 0.76. CEPH
samples 1331-1 and 1331-2 were included as size stan-
dards in all PCRs and gel runs. Internal standards were
also included in each gel lane. Gel electrophoresis was
performed on an ABI Prism 377 DNA sequencer instru-
ment (Perkin Elmer), and genotypes were assigned using
Genotyper 2.0 software (Perkin Elmer). Two individuals
scored the alleles independently. Discrepancies were
ﬂagged and resolved.
Ten samples did not amplify for 125% of the markers
and were dropped from the analysis. Of these 10, only
one sample was from an affected proband; the other 9
were samples from unaffected relatives or parents. The
overall error rate was 0.09%, and the inconsistency rate
was 0.30%. The missing data rate was 6.6%.
Error Checking
We veriﬁed familial relationships through use of the
GRR (Abecasis et al. 2001b) and RELPAIR (Epstein et
al. 2000) programs. Four families showed segregation
problems that were consistent with a sample switch in
two of the families and with nonpaternity in the other
two. After resolving problems in family structure, we
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Table 1
Peak Single-Point LOD Scores Observed in the
Nonparametric Linkage Analysis
CHROMOSOME
AND MARKERa
LOCATIONb
(cM)
LOD SCORE FOR
LC I LC II LC III
1:
D1S2660 11 … 1.04 …
D1S1612 16 2.28 3.21 3.30
D1S1653 164 1.14 … …
3:
D3S2406 103 … … 1.00
4:
D4S2366 13 … … 1.04
6:
D6S2436 155 1.08 … …
8:
D8S1469 16 1.06 … …
D8S1130 22 1.46 … …
D8S136 44 1.16 … …
9:
D9S1122 76 … 1.84 2.20
D9S1826 160 … … 1.10
13:
D13S1265 99 1.88 1.04 …
D13S285 111 1.98 … …
17:
D17S974 22 1.41 … …
18:
D18S858 80 1.12 … 1.12
21:
D21S1446 58 1.07 … …
X:
DXS6800 93 … 1.40 1.24
a All markers with a LOD score (Kong and Cox 1997)
11.0 in the single-point analyses are shown.
b Marker locations are given according to the Marsh-
ﬁeld genetic map.
used MERLIN (Abecasis et al. 2002) to check for Men-
delian inconsistencies and to identify genotypes associ-
ated with an excessive number of recombination events.
Nonparametric Linkage Analysis
We performed genomewide, nonparametric linkage
analyses using the SALL statistic (Whittemore and Halpern
1994), as recommended by Sengul et al. (2001). This sta-
tistic combines information from all affected individuals
in a pedigree and can detect regions of excess identity-
by-descent sharing. We conducted these analyses with the
MERLIN computer program (Abecasis et al. 2002) and
calculated LOD scores as described elsewhere (Kong and
Cox 1997). We performed both multipoint and single-
point analyses throughout the genome. Although multi-
point linkage analysis is theoretically more powerful, it is
also more sensitive to errors in genotype data or genetic
map speciﬁcation (Abecasis et al. 2001a; Sullivan et al.
2003). In contrast, single-point analysis is less efﬁcient
and more prone to random stochastic ﬂuctuations, but it
is more robust to genotyping error and does not require
speciﬁcation of genetic maps (Abecasis et al. 2001a; Sul-
livan et al. 2003).
Parametric Linkage Analysis
We repeated the linkage analyses using a set of four
parametric models for schizophrenia, as described by
Brzustowicz et al. (2000), corresponding to dominant
and recessive models for LCs I and II. For LC I, when
a dominant model was assumed, we set the allele
frequency at with penetrance vectorpp 0.0045 fp
. If we assume a recessive model,[0.75, 0.50, 0.001]
and . Elements ofpp 0.065 fp [0.50, 0.0015, 0.0015]
the penetrance vector f are ordered to denote the prob-
ability of disease for genotypes with frequency p2,
, and , respectively. For LC II, when22(1 p)p (1 p)
a dominant model was assumed, andpp 0.007 fp
. For the recessive model, and[0.90, 0.80, 009] pp 0.10
. These analyses were conductedfp [0.60, 0.01, 0.01]
with the Allegro computer program (Gudbjartsson et al.
2000).
Empirical Signiﬁcance Levels
We calculated genomewide signiﬁcance levels through
use of 5,000 gene-dropping simulations. In each simu-
lation, we retained the original phenotypes and gener-
ated a new data set with the same allele frequencies,
marker spacing, phenotypes, and missing data pattern.
Any evidence for linkage in these simulated data is due
to chance. We analyzed each replicate and recorded the
highest peak for each chromosome, to evaluate the false-
positive rate. These simulations allowed us to account
for uneven marker spacing and informativeness and for
the diversity of family structures in our study, as well as
to calculate the probability of observing multiple linkage
peaks of a certain height. For a discussion of the utility
of empirical signiﬁcance levels in linkage analysis, see
Kruglyak and Daly (1998).
Fine Mapping
A denser marker map was generated for the three
chromosomal regions where markers showed a LOD
score 11.5 in the original scan. The additional markers
analyzed were selected from the Marshﬁeld genetic
maps, and their order was cross checked with the current
genome assembly prior to analysis. CEPH samples 1331-
1 and 1331-2 were included as size standards in all PCRs
and gel runs. Internal standards were also included in
each gel lane. Gel electrophoresis was performed on an
ABI 3700 DNA sequencer instrument at the Starr Center
Genotyping Facility at the Rockefeller University. Ge-
notypes were assigned using Genotyper 2.5 software
(Perkin Elmer). Two individuals scored the alleles in-
dependently. Discrepancies were ﬂagged and resolved.
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Table 2
Empirical Genomewide P Values for Markers with Observed Nonparametric Peak LOD Scores
11.0
LC AND
RANK (r)a MARKER LOCATIONb
OBSERVED
LOD
SCORE
(Z)
EXPECTEDc
P (r LODs Z)d
E(No. of LOD
Scores Z) SD
LC I:
1 D1S1612 16 2.28 .07 .27 .072
2 D13S285 111 1.98 .40 .62 .060
3 D8S1130 22 1.46 1.67 1.23 .230
4 D17S974 22 1.41 1.94 1.32 .122
5 D18S858 80 1.12 4.16 1.81 .406
6 D6S2436 155 1.08 4.56 1.88 .294
7 D21S1446 58 1.07 4.66 1.90 .163
LC II:
1 D1S1612 16 3.21 .01 .08 .006
2 D9S1122 76 1.84 .75 .84 .171
3 D13S1265 99 1.04 4.74 1.89 .887
LC III:
1 D1S1612 16 3.30 .01 .08 .007
2 D9S1122 76 2.20 .20 .54 .035
3 D18S858 80 1.12 3.85 1.74 .771
4 D4S2366 13 1.04 4.54 1.83 .698
5 D3S2406 103 1.00 4.93 1.89 .571
a For each phenotypic liability class, the table ranks markers exhibiting the strongest evidence for
linkage.
b Chromosomal locations are given in centimorgans only; chromosome assignments are implicit
in the marker name.
c The expected number of chromosomes exhibiting equal or greater LOD scores (and its SD).
d The probability that r LOD scores of equal or greater magnitude would be observed by chance.
The probabilities and expected values were estimated from 5,000 sets of genotypes generated under
the null (see text). This simulation considered only autosomes 1–22.
Overall, 19 additional markers (D1S2893, D1S2795,
D1S2694, D1S1160, D1S503, D1S2736, D1S434,
D1S507, D9S175, D9S153, D9S152, D13S174,
D13S248, D13S778, D13S1295, D13S1315, D13S261,
D13S293, and D13S1825) were investigated in regions
showing evidence of linkage on chromosomes 1, 9, and
13. Marker D1S2694 showed clear evidence for depar-
ture from Hardy-Weinberg equilibrium ( ) andP ! .0007
was excluded from further analyses.
Results
Nonparametric Linkage Analysis
We initially performed single-point, nonparametric
linkage analysis (Whittemore and Halpern 1994) using
the NPL-ALL statistic (as recommended by Sengul et al.
2001). NPL Z scores were converted into LOD scores,
as described elsewhere (Kong and Cox 1997). A sum-
mary of all estimated LOD scores is given in ﬁgure 2.
In addition, observed LOD scores of 1.0 are sum-
marized in table 1. Overall, we observed the strongest
evidence for linkage on chromosome 1 at marker
D1S1612 (LOD score 2.28, asymptotic forPp .0006
LC I; LOD score 3.21, for LC II; and LODPp .00006
score 3.30, for LC III). Markers D9S1122Pp .00005
on chromosome 9 (LOD score 1.84, for LCPp .002
II; and LOD score 2.20, for LC III) andPp .0007
D13S1265 on chromosome 13 (LOD score 1.88, Pp
for LC I) also exhibit strong evidence for linkage..002
Empirical Signiﬁcance Levels
We used gene-dropping simulations to estimate ge-
nomewide P values for our observed linkage signals. The
results of these simulations are summarized in table 2.
In our sample, the probability of observing one or more
chromosomes with a LOD score 3.30 for LC III (the
LOD score we observed at D1S1612) by chance is
(see table 2). Less than 1 such signal is ex-Pp .007
pected to occur by chance in every 100 genome scans.
Even after accounting for our use of three different phe-
notypic liability classes, the probability of observing a
LOD score of 3.30 is only .012.
For LCs I and II, the highest observed LOD scores are
2.28 and 3.21, respectively, and the probability of ob-
serving one or more chromosomes with equal or greater
LOD scores by chance is and , re-Pp .072 Pp .006
spectively. It is noteworthy that, for LC I, we observed
evidence for linkage in more chromosomes than ex-
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Table 3
Peak Multipoint LOD Scores from the Nonparametric Linkage Analysis
CHROMOSOME
AND NEAREST
MARKER
LC I LC II LC III
LOD
Locationa
(cM)
Intervalb
(cM) LOD
Locationa
(cM)
Intervalb
(cM) LOD
Locationa
(cM)
Intervalb
(cM)
1:
D1S1612 1.48 16 13–21 2.99 16 9–25 2.44 16 9–25
9:
D9S1118 … … … 1.19 61 59–64 … … …
D9S1122 … … … 1.32 76 69–78 1.57 76 71–92
13:
D13S285 2.23 109 93–111 1.53 110 101–111 1.31 109 102–111
17:
D17S2196 … … … … … … 1.13 45 42–46
D17S928 … … … … … … 1.04 123 120–126
21:
D21S1446 1.40 56 46–58 … … … … … …
NOTE.—The table lists all linkage peaks with a LOD score (Kong and Cox 1997) 11.0 in the multipoint analyses.
a LOD score location (according to the Marshﬁeld genetic map) for each peak.
b Interval in which the LOD score is 11.0.
pected by chance. For example, at LOD score thresholds
of 2.28, 1.98, 1.41, and 1.08, we observed evidence for
linkage in one, two, four, and six chromosomes, re-
spectively. In contrast, we would expect to observe ev-
idence for linkage in only 0.07, 0.40, 1.97, and 4.56
chromosomes at each of these thresholds. Although this
excess of linkage peaks does not reach genomewide sig-
niﬁcance levels, it is consistent with an oligogenic basis
for schizophrenia, which would produce modestly in-
creased allele sharing at a number of loci rather than
large increases in sharing at a few loci (Cookson et al.
[2001] present a similar analysis for eczema).
Table 2 also illustrates the utility of calculating anal-
ysis- and data-speciﬁc thresholds when evaluating ge-
nomewide signiﬁcance levels. For example, at threshold
1.12, 4.16 linkage peaks are expected to occur by chance
for LC I, but only 3.85 such peaks are expected for LC
III. This is the result of differences in informativeness
between the two phenotypic liability classes in our sam-
ple (for example, there are more affected individuals per
family for LC III, and the proportion of different types
of relative pairs is different for each LC).
Multipoint Nonparametric Linkage Analysis
Multipoint results are largely consistent with the sin-
gle-point analyses (table 3; ﬁg. 3). Strong evidence for
linkage is observed on chromosome 1 (near marker
D1S1612 at 16 cM), with LOD scores of 1.48 (Pp
), 2.99 ( ), and 2.44 ( ), for LCs.005 Pp .0001 Pp .0004
I, II, and III, respectively. As in the single-point analyses,
two other modest linkage peaks were observed on chro-
mosomes 9 and 13, with peak LOD scores of 1.57
( ) for LC III and 2.23 ( ) for LC I,Pp .004 Pp .0007
respectively. Concordance between the multipoint and
single-point analyses increases our conﬁdence that these
linkage signals are real and not artifacts generated by
genotyping or map error.
In inbred samples, LOD scores may be inﬂated (Genin
and Clerget-Darpoux 1996). This is a phenomenon that
could result in misleading inferences about linkage. To
ensure that this was not the case in the sample of nuclear
families we selected for genotyping, we calculated av-
erage nonparametric LOD scores (Kong and Cox 1997)
at 1-cM intervals throughout the genome, through use
of the LC III phenotype deﬁnition (data not shown). At
each location, we set the sign of the LOD score to pos-
itive if there was evidence for excess sharing among af-
fected individuals and to negative otherwise. We ob-
served an average LOD score of 0.03, suggesting that
inbreeding is not a serious cause for concern in inter-
preting our results.
Parametric Linkage Analysis
We ﬁrst calculated parametric LOD scores formarkers
on chromosomes 1, 9, and 13, which exhibited the
strongest evidence for linkage in multipoint and single-
point nonparametric analyses. We considered four pre-
viously described disease models (Brzustowicz et al.
2000) and performed analyses both with and without a
heterogeneity parameter. We speculated that these anal-
yses might help evaluate different modes of action for
susceptibility genes that may be segregating in our
population.
Our peak LOD scores in single-marker analyses were
3.26 for marker D1S1612 (chromosome 1, 16 cM, LC
II), 2.17 for marker D9S1122 (chromosome 9, 76 cM,
LC II), and 1.79 for marker D13S285 (chromosome 13,
111 cM, LC I). Multipoint results also conﬁrmed the
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Figure 3 Multipoint analysis results. Multipoint Kong and Cox (1997) nonparametric LOD scores calculated using the SALL scoring statistic
are shown. Results are summarized throughout the genome for three phenotypic LCs: LC I (solid black line), LC II (dashed line), and LC III
(solid gray line).
results of our nonparametric analyses, although ob-
served LOD scores were somewhat higher on chromo-
some 13, where the peak LOD score increased to 3.11
(chromosome 13, 106 cM, LC I), and somewhat lower
on chromosomes 1 and 9, with peak LOD scores of 2.95
(chromosome 1, 16 cM) and 1.59 (chromosome 9, 75
cM). Analyses allowing for heterogeneity raised ob-
served LOD scores only slightly.
A summary of our parametric analyses, including de-
tails of linkage peaks for each chromosome and analysis
model, is provided in table 4. Although we observed the
strongest evidence for linkage when we assumed a re-
cessive disease model with high penetrance, it is impor-
tant to note that small pedigrees have very limited utility
for distinguishing between different disease models (for
a detailed discussion of the issue, see Go¨ring and Ter-
williger [2000]), and one must be cautious in assuming
that this model is closest to the truth.
We also performed parametric linkage analyses for the
rest of the other autosomes. In single-marker analyses,
the three markers exhibiting the strongest evidence
for linkage were D3S2460 (heterogeneity LOD score
[HLOD] 2.34 with , using LC I and the re-ap 0.29
cessive model), D18S858 (HLOD 2.28 with ,ap 0.10
using LC II and the recessive model), and D8S1130
(HLOD 1.70with , using LC I and the recessiveap 0.33
model). Parametric multipoint analyses did not identify
any regions outside chromosomes 1, 9, and 13 where
LOD scores were 11.5 or HLODs were 11.5. Detailed
tables, including all our parametric linkage results, are
available online (authors’ Web site).
Fine Mapping
We genotyped additional markers around our chro-
mosome 1, 9, and 13 linkage peaks. We reasoned that
these markers might help extract additional linkage in-
formation in these regions. In total, we genotyped eight
new markers around each of our two highest peaks,
on chromosomes 1 and 13, and three additional mark-
ers around the chromosome 9 linkage peak. These
chromosomes were selected because they provided sug-
gestive evidence for linkage (LOD score 11.5) in para-
metric and nonparametric analyses, whether single-
point or multipoint.
Overall, evidence for linkage to chromosome 1 weak-
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Table 4
Multipoint and Single-Point Parametric Linkage Analysis Results for Chromosomes 1, 9, and 13
CHROMOSOME,
LC, AND MODEL
HOMOGENEITY HETEROGENEITY
Single-Point Multipoint Single-Point Multipoint
Marker
(Position in cM) LODa
Position
(cM) LODa
Marker
(Position in cM) ab HLODc
Position
(cM) ab HLODc
1:
LC I:
Dominant D1S1653 (164) 1.94 14 .26 D1S1653 (164) .00 1.94 14 .37 .86
Recessive D1S1612 (16) 2.97 16 1.34 D1S1612 (16) .11 3.04 16 .33 2.17
LC II:
Dominant D1S1612 (16) 1.67 14 1.49 D1S1612 (16) .20 1.98 14 .21 1.74
Recessive D1S1612 (16) 3.26 16 2.95 D1S1612 (16) .00 3.26 16 .13 3.04
9:
LC I:
Dominant D9S1122 (76) .24 50 2.15 D9S1122 (76) .34 1.06 76 .73 .28
Recessive D9S1826 (160) .69 51 .35 D9S1826 (160) .27 1.27 164 .51 1.42
LC II:
Dominant D9S1122 (76) .84 50 1.99 D9S1122 (76) .28 1.50 76 .62 .55
Recessive D9S1122 (76) 2.17 75 1.59 D9S1122 (76) .08 2.20 75 .24 1.88
13:
LC I:
Dominant D13S1265 (99) .64 105 1.84 D13S1265 (99) .32 1.48 104 .12 1.86
Recessive D13S285 (111) 1.79 106 3.11 D13S1265 (99) .34 2.26 106 .09 3.15
LC II:
Dominant D13S894 (33) 1.78 106 .59 D13S1265 (99) .60 .66 104 .54 .78
Recessive D13S1265 (99) 1.78 107 2.48 D13S1265 (99) .28 2.15 107 .13 2.54
NOTE.—Boldface italic type indicates the combinations of LC and disease model that resulted in the strongest evidence for linkage.
a Parametric LOD score calculated under the assumption of no heterogeneity.
b Estimated value at each location.
c Parametric LOD score maximized over a heterogeneity parameter a.
ened somewhat, with the peak nonparametricmultipoint
LOD score decreasing from 2.99 (for LC II at 16 cM)
to 2.36 (also for LC II, but at 15 cM). In contrast, ev-
idence for linkage on chromosomes 9 and 13 increased.
On chromosome 9, the peak nonparametric LOD score
increased from 1.57 (for LC III at 76 cM) to 1.83 (also
for LC III, but at 87 cM). On chromosome 13, the peak
nonparametric LOD score increased from 2.23 (for LC
I at 109 cM) to 3.01 (also for LC I, at 111 cM). A
comparison of our linkage peaks in the original and ﬁne-
mapping panels is provided in ﬁgure 4. We cautiously
interpret these results as corroboration of our linkage
peaks.
Chromosome 1 Isodisomy
Close inspection of the Mendelian inconsistencies in
our sample revealed that 13 of them occurred in a single
family, all for markers on chromosome 1. Mendelian
consistency for all markers on the X chromosome and
for autosomes 2–22 suggests that nonpaternity (or non-
maternity) is not an issue. In this family, the proband is
homozygous for all chromosome 1 markers and does
not carry a maternally derived allele at 13 of these mark-
ers (ﬁg. 5A). The genotypes for 30/32 chromosome 1
markers are consistent with a paternal isodisomy for the
entire chromosome; genotypes are not available for the
other two markers. This observation is intriguing, in
light of the fact that our strongest linkage signal is also
on chromosome 1 and our parametric analyses suggest
a recessive mode of inheritance (all our peak LOD scores
were observed with the recessive model). It is interesting
that genealogical tracing revealed that the isodisomic
individual belongs to a previously described cluster (Ka-
rayiorgou et al. 2004) of 87 individuals meeting our
strict deﬁnition for schizophrenia (LC I) and descending
from a single founder couple. The same cluster currently
includes 12 of the 34 families we used in our linkage
analyses (ﬁg. 5B).
Discussion
Current attempts to identify genetic loci for schizophre-
nia include the use of founder populations as a way to
limit the genetic and environmental heterogeneity. Iso-
lated populations established by a limited number of
founders have proven useful for mapping genes of rare
monogenic disorders (Hastbacka et al. 1994; Kalay-
djieva et al. 1996; Nystuen et al. 1996; Visapaa et al.
2002). Their usefulness in mapping complex traits is still
largely untested. Although it is perhaps unreasonable to
412 Am. J. Hum. Genet. 74:403–417, 2004
Figure 4 Comparison of original and ﬁne-mapping results. Multipoint Kong and Cox (1997) nonparametric LOD scores calculated using
the SALL scoring statistic are shown. Results are summarized for three regions exhibiting strongest evidence for linkage, on chromosomes 1, 9,
and 13. The three phenotypic LCs are LC I (solid black lines), LC II (lines with long dashes), and LC III (lines with short dashes).
expect that there be one major (monogenic disorder–
like) susceptibility locus in genetic studies of complex
traits such as schizophrenia, one can reasonably expect
a smaller number of contributing loci and a smaller num-
ber of disease alleles at each locus for at least some
founder populations.
Here, we report initial results from a 10-cM ge-
nomewide scan of families with schizophrenia from the
Afrikaner population. Thirty-four two- to four-gener-
ation pedigrees with at least one individual meeting
strict DSM-IV criteria for schizophrenia or schizoaffec-
tive disorder were informative for linkage. Using both
nonparametric and parametric linkage analyses, we ob-
tained evidence for a small number of disease loci on
chromosomes 1, 9, and 13. These results are consistent
with the notion that genes of substantial effect exist for
schizophrenia in the Afrikaner population.
Our chromosome 9 and 13 ﬁndings do not reach
genomewide signiﬁcance levels but do show suggestive
overlap with other studies. The locus on chromosome
9 overlaps with the locus described by Hovatta et al.
(1999) in families from Finland. In the Finnish study, a
maximum LOD score of 1.95 was obtained withmarker
D9S922 (3.4 cM telomeric to our most signiﬁcant
marker, D9S1122). It is interesting that positive ﬁndings
in this region have been reported in the genome scans
of Moises et al. (1995) and Levinson et al. (1998), 6
cM centromeric and 16 cM telomeric to our marker
D9S1122, respectively.
The locus on chromosome 13 is slightly distal to the
locus described by Blouin et al. (1998). Ourmost positive
marker, D13S285, maps 14 cM telomeric to D13S174,
the most positive marker in the Blouin et al. (1998) study.
Recent results from a linkage disequilibrium–based po-
sitional cloning effort centered around marker D13S174
suggest an association between schizophrenia suscepti-
bility and the G72 gene, which encodes a protein that
may interact and modulate the activity of D-amino-acid-
oxidase (Chumakov et al. 2002). Recent association stud-
ies suggest a potential contribution of G72 to bipolar
disorder as well (Hattori et al. 2003). G72 is located 3.2
Mb and 7 Mb proximally from markers D13S1265 and
D13S285, respectively, which gave the best linkage results
in our studies. Association studies in an extended sample
of Afrikaner families revealed a weak contribution of the
G72 gene in our sample (D.H., J.A.G., and M.K., un-
published data), but it is not yet clear whether this can
account for the observed linkage signal.
We also obtained strong evidence for an apparently
novel locus on chromosome 1. Although other studies
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Figure 5 Isodisomic individual. A, Chromosome 1 genotypes for isodisomic individual and two parents. The isodisomic chromosome is
shaded in black, and asterisks (*) indicate markers where mother and offspring genotypes are incompatible. B, Shortest connection between
individuals in LC I and a single ancestor who emigrated to South Africa ∼12 generations before present (Karayiorgou et al. 2004). Most affected
individuals in our sample are connected to this founder through multiple descent routes. Twelve small pedigrees suitable for linkage analysis
and included in our sample are boxed in the diagram. The cluster includes additional informative families when LCs II and III are used. The
isodisomic individual is indicated by an arrow (F).
have implicated chromosome 1 in schizophrenia, the
region identiﬁed in the present study is quite distant
from the previously implicated regions, ∼148–154 cM
from the locus described by Brzustowicz et al. (2000)
and ∼208 cM from the locus described by Hovatta et
al. (1999), both of which are in the q arm of chro-
mosome 1. Our study demarcates a region on the p arm
of chromosome 1 at ∼16 cM, which has not been im-
plicated previously, with the possible exception of a re-
cent genome scan in Icelandic families (Stefansson et al.
2002), in which a region on chromosome 1 that appears
to overlap with ours provided a weak linkage signal.
It is most interesting that we identiﬁed one proband
with uniparental disomy (UPD) for paternal chromo-
some 1. UPD, which was ﬁrst described by Engel (1980),
is a rare condition in which a diploid individual inherits
two copies of a speciﬁc chromosome from one parent
and no copy from the other parent. UPD may lead to
rare recessive disorders or to developmental distur-
bances due to aberrant imprinting effects (Ledbetter and
Engel 1995), or it may have no apparent phenotypic
effects. There are very few reported cases of UPD of
chromosome 1 (UPD 1), involving full or partial iso-
disomy. These include a small number of cases of ma-
ternal UPD 1 (Pulkkinen et al. 1997; Field et al. 1998;
Dufourcq-Lagelouse et al. 1999), as well as a few cases
of paternal UPD 1 (Gelb et al. 1998; Chen et al. 1999;
Miura et al. 2000; Takizawa et al. 2000; Thompson et
al. 2002). Among the latter, UPD 1 has been associated
with (a) retinal dystrophy due to mutations in the
RPE65 gene (Thompson et al. 2002), (b) congenital
insensitivity to pain with anhidrosis due to mutations
of the TRKA gene (Miura et al. 2000), (c) Herlitz junc-
tional epidermolysis bullosa due to mutation inLAMC2
(Takizawa et al. 2000), or (d) pycnodysostosis due to
mutations in the cathepsin K gene (Gelb et al. 1998).
All described individuals with UPD 1 developed nor-
mally, suggesting that chromosome 1 does not carry
developmentally important maternally imprinted genes,
although the existence of maternally imprinted genes
with subtler effects on brain function and behavior can-
not be excluded. The proband described here also had
normal development (J.L.R. and M.K., unpublished
data). To our knowledge, this is the ﬁrst time a UPD of
any chromosome has been described in a patient with
schizophrenia and the second time a UPD has been dis-
covered during a genome screen linkage study (the other
one was described by Field et al. [1998]). On the basis
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of the striking coincidence of linkage and UPD on chro-
mosome 1 and the genealogical evidence, it is tempting
to speculate that this individual might be homozygous
for a chromosome 1 schizophrenia-susceptibility locus
segregating in the Afrikaner population. If this were the
case, we might be able to exploit this fortuitous chro-
mosomal abnormality in our attempts to identify and
reﬁne an Afrikaner risk haplotype on chromosome 1.
Speciﬁcally, additional genotyping might allow us to
identify regions of this individual’s haplotype that are
shared by other individuals with schizophrenia. This
focused search for sharing of a particular haplotype is
simpler and more powerful than a search for any shared
haplotype because it reduces multiple testing. This work
is currently in progress.
It has been suggested that genes inﬂuencing suscep-
tibility to schizophrenia and other psychiatric disorders
may have pleiotropic effects (Collier and Sham 1997).
In addition to the standard deﬁnitions of schizophrenia
used in genetic studies (LC I and LC II), we also con-
sidered other psychiatric disorders found in relatives of
schizophrenic individuals in the sample used in our
study (LC III). The latter classiﬁcation results in small
increases in evidence for linkage for the chromosome 1
and 9 loci. This observation is compatible with the hy-
pothesis that schizophrenia-susceptibility genes might
lead to other psychiatric disorders in the relatives of
patients with schizophrenia and that the clinical man-
ifestation of these genes depends on interactions with
the environment, other genes, and/or stochastic factors.
In summary, in the current study, we obtained evi-
dence for schizophrenia loci on three chromosomes: 1,
9, and 13. Genealogical evidence shows that the affected
individuals in our sample shared a relatively recent an-
cestor and are likely to share schizophrenia-suscepti-
bility genes. If any schizophrenia-susceptibility alleles
were inherited through the shared line of descent we
have identiﬁed in our sample (Karayiorgou et al. 2004),
they are likely to be surrounded by a relatively large
haplotype, which will facilitate ﬁne-mapping efforts.
Nevertheless, it is possible that different lines of descent
are important and that identifying the susceptibility al-
leles we are seeking will require extensive ﬁne mapping
with hundreds of markers. It is fortunate that these ap-
proaches are rapidly becoming feasible (Cardon and
Abecasis 2003). Although we are cautious about ov-
erinterpreting the signiﬁcance of these loci, at a mini-
mum, our ﬁndings warrant further studies using our
data set and independent data sets from the Afrikaner
population. It is most important that, given the advan-
tage of accurate genealogical tracing in this population,
future studies will attempt to identify any extensive
shared haplotypes by using denser 1–2-cM microsat-
ellite maps, both at the identiﬁed loci and at the ge-
nomewide level.
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